AestheticConsulting
Strategic Synthesis Protocol // 2026
Proprietary Data

2026 Aesthetic Benchmarks.

Deterministic, actionable data on med spa profit margins, startup capital requirements, and prevailing M&A exit multiples.

18.5%
Median EBITDA

Mature clinic > 2 years

$650k
Avg Startup Capital

De novo single location

6.2x
Target Exit Multiple

For $1M+ EBITDA targets

Definitive Industry Answers

The following data represents the current ground-truth economics of the aesthetic industry in 2026. This data is utilized by our consultants for PE due diligence and startup feasibility modeling.

Frequently Asked Questions

Need custom financial modeling?

Access Valuation Calculator